J Neurol Neurosurg Psychiatry 86:3 doi:10.1136/jnnp-2014-308297
  • Editorial commentary

Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?

Press Release
  1. Mia L van der Kop
  1. Correspondence to Mia van der Kop, Epidemiologist, University of British Columbia Centre for Disease Control, Doctoral student, Department of Public Health Sciences, Karolinska Institutet, 655 12th Avenue West, Vancouver, British Columbia, Canada V57 4R4; miavanderkop{at}
  • Received 2 June 2014
  • Revised 3 June 2014
  • Accepted 4 June 2014
  • Published Online First 4 August 2014

In 2011, a case was reported in which a patient with multiple sclerosis (MS) and HIV was treated with antiretroviral therapy (ART)—he did not experience MS-related deficits for over a decade.1 This prompted researchers in Denmark (Nexø et al) to examine the association between MS and HIV using population-based databases. Although they found a reduced incidence of MS in HIV-positive individuals compared with the general population, their study did not achieve a conventional level of statistical significance.2 I was recently asked to review the Gold et al study,3 which has answered the Danish researchers’ call for a larger study to investigate whether HIV, or its treatment, has a protective effect on the development of MS.

Similar to the original Danish study, Gold et al used administrative health databases to fulfil their research objectives; in …

Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article